Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 4 of 4 for “"Rnase R"”.

  1. An Investigation of Bacterial Ribonucleases as an Antibiotic Target

    … is processed by bacterial ribonucleases (RNases). RNases are also involved in the degradation and turnover of this RNA during times of stress, such as the presence of an antibiotic. This makes ribonucleases a potential target for novel antibiotics.</p><p>It was shown that <em>Escherichia …

    etsu Repository record for An Investigation of Bacterial Ribonucleases as an Antibiotic Target (opens in a new tab)

  2. Implementation of circFISH to quantify the expression and cellular localization of circNFIX in cerebral palsy

    … healthy controls were observed. Additionally, RNAse R treatment resulted in significant reduction in linNFIX levels with minimal change in circNFIX levels. CircNFIX knockdown SCs showed significant reduction in circNFIX counts. Significant differences in nuclear and cytoplasmic distribution of …

    udel Repository record for Implementation of circFISH to quantify the expression and cellular localization of circNFIX in cerebral palsy (opens in a new tab)

  3. Caractérisation des arns circulaires du gène pax-5 dans les cancers lymphoïdes

    … et leur résistance à un traitement à la RNase R (exonucléase ARN-dépendante). L'analyse des profils d'expression des circPax5 démontre que ceux-ci sont exprimés dans des lymphocytes B primaires (échantillons cliniques) ainsi que dans des lignées. De plus, nos observations …

    moncton Repository record for Caractérisation des arns circulaires du gène pax-5 dans les cancers lymphoïdes (opens in a new tab)

  4. Roles of non-Cas nucleases in Type III-A CRISPR-Cas immunity

    Submission published under a 24 month embargo labeled 'U of I Access', the embargo will last until 2025-08-01

    uiuc Repository record for Roles of non-Cas nucleases in Type III-A CRISPR-Cas immunity (opens in a new tab)